Literature DB >> 2177086

The herpes simplex virus type 1 alkaline nuclease is not essential for viral DNA synthesis: isolation and characterization of a lacZ insertion mutant.

S K Weller1, M R Seghatoleslami, L Shao, D Rowse, E P Carmichael.   

Abstract

Herpes simplex virus type 1 (HSV-1) encodes a novel enzyme activity, the alkaline nuclease, whose precise role in the viral replication cycle remains obscure. The alkaline nuclease gene corresponds to the UL12 open reading frame, which is predicted to encode a protein of 626 amino acid residues. We describe the isolation and characterization of a null mutant of the gene for the viral alkaline nuclease in which 917 bp from the N-terminal half of the gene (corresponding to residues 70 to 375) were deleted and replaced by the insertional mutagen ICP6::lacZ. The resulting mutant virus, AN-1, was propagated in helper cells (S22) which express the wild-type version of the alkaline nuclease gene. Mutant AN-1 growth in Vero cells is severely restricted, although small amounts of infectious virus are produced. On the other hand, wild-type levels of viral DNA and late viral proteins are expressed in virus AN-1-infected Vero cells. These results indicate that the HSV-1 alkaline nuclease gene product is not essential for viral DNA synthesis but may play a role in the processing or packaging of viral DNA into infectious virions. Possible roles in the viral infectious cycle will be discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177086     DOI: 10.1099/0022-1317-71-12-2941

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  45 in total

1.  The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22.

Authors:  F C Purves; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Characterization of a baculovirus lacking the alkaline nuclease gene.

Authors:  Kazuhiro Okano; Adam L Vanarsdall; George F Rohrmann
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Packaging determinants in the UL11 tegument protein of herpes simplex virus type 1.

Authors:  Joshua S Loomis; Richard J Courtney; John W Wills
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

4.  The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication.

Authors:  R Feederle; H Bannert; H Lips; N Müller-Lantzsch; H-J Delecluse
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

5.  Association between the herpes simplex virus major DNA-binding protein and alkaline nuclease.

Authors:  M S Thomas; M Gao; D M Knipe; K L Powell
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  The UL5 gene of herpes simplex virus type 1: isolation of a lacZ insertion mutant and association of the UL5 gene product with other members of the helicase-primase complex.

Authors:  L A Zhu; S K Weller
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

7.  Role of the nuclease activities encoded by herpes simplex virus 1 UL12 in viral replication and neurovirulence.

Authors:  Hikaru Fujii; Michio Mugitani; Naoto Koyanagi; Zhuoming Liu; Shumpei Tsuda; Jun Arii; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

8.  Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates.

Authors:  R Martinez; R T Sarisky; P C Weber; S K Weller
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids.

Authors:  Ken Sagou; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

10.  The UL12.5 gene product of herpes simplex virus type 1 exhibits nuclease and strand exchange activities but does not localize to the nucleus.

Authors:  Nina Bacher Reuven; Susumu Antoku; Sandra K Weller
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.